Active B12 Test Market Global Industry Analysis and Forecast (2025-2032)

Active B12 Test Market Overview The Active B12 Test Market was valued at USD 227.24 million in 2024 and is projected to reach USD 1,328.67 million by 2032, growing at a CAGR of 24.7% during the forecast period. Active B12, also known as holotranscobalamin, measures the biologically available form of vitamin B12, making it more accurate for diagnosing deficiencies than total B12 assays. Rising global awareness regarding vitamin B12 deficiency, particularly among the aging population and individuals with restrictive diets, is a significant driver for market expansion. The shift towards preventive healthcare and early diagnosis further fuels demand for reliable testing solutions. Competitive Analysis The market landscape is competitive and marked by continuous innovation, especially in assay development and diagnostic technology. Companies are focusing on enhancing test accuracy, reducing turnaround time, and increasing automation to stay ahead. However, the market faces hurdle...